Abzena, Alira Health and Oncodesign launch DRIVE-Biologics to support access to specialist services from discovery to clinical development for oncology and inflammation
Biomunex and Institut Curie pursue strategic collaboration for development of disruptive non-conventional T cell redirection approach to treating cancer
Human Cell Design launches Endoc-BH5, an advanced human beta cell model enabling new discoveries in type 1 and 2 diabetes research
Tollys accelerates development of TLR3 agonist candidates for intravenous administration in immuno-oncology
Tollys accelerates development of TLR3 agonist candidates for intravenous administration in immuno-oncology
CONDOR project for precision medicine and sarcoma immunotherapy awarded close to €10M in the fifth call for Hospital-University Research in Health (RHU) projects
Seekyo reinforces scientific advisory board with two new members
NovAliX acquires Sanofi site in Strasbourg and creates Guy Ourisson Research Campus
Univercells acquires SynHelix, entering into synthetic biology and the race to next-generation DNA synthesis
Genoscience Pharma licences GNS561, its PPT-1 inhibitor, to GENFIT in cholangiocarcinoma indication in US/Canada and Europe
Phase 2 clinical program in cholangiocarcinoma expected to start first half of 2022